From failed implant to no bone left: the infection cascade that forecloses future treatment

Disclosure. Dr. Maloney has no commercial relationship with any clinic, marketplace, manufacturer, or industry body in Turkey or elsewhere. She did not receive payment, travel, accommodation, equipment, or any other consideration in connection with this piece. Standing disclosures are at /disclosures/. Last reviewed: 2026-06-03.

There is a category of dental tourism failure that does not make the press. The crown that falls off photographs well. The peg tooth produces a memorable image. The implant pushed through a sinus produces a scannable CT image that the BBC can broadcast. These cases receive coverage because they are visually legible to a non-clinical audience.

The failure mode this piece describes is less photogenic. It presents on a periapical radiograph as a greyish halo around an implant that three months ago looked fine. It presents clinically as bleeding that the patient attributes to brushing too hard, bone loss that is invisible until it isn’t, and a slow-moving infection that, by the time the patient notices it, has already made the decisions about her future treatment options.

It is peri-implantitis. It is the commonest implant complication in the peer-reviewed literature. And it is the one most likely to be set in motion by the combination of rushed placement, absent follow-up, and inadequate pre-treatment screening that characterises the high-volume dental tourism model.

What peri-implantitis is and how it starts

Peri-implantitis is bacterial infection of the tissues surrounding a dental implant, producing progressive bone loss. It is the implant equivalent of periodontitis around natural teeth: a plaque-mediated inflammatory disease in which the body’s immune response, triggered by biofilm at the implant surface, destroys the bone that supports the fixture.

The distinction from peri-implant mucositis matters. Mucositis is inflammation of the soft tissue surrounding an implant without bone loss. It is reversible: remove the biofilm, resolve the inflammation, and the soft tissue recovers. Peri-implantitis involves bone loss, and that bone loss is largely not reversible without surgical intervention. Once the supporting bone is gone, it does not regenerate on its own.

Derks and Tomasi’s 2015 systematic review remains the most-cited epidemiological reference on peri-implant disease. Across the studies included in the review, peri-implant mucositis affected approximately 43% of implant sites, and peri-implantitis (with bone loss) affected approximately 22% of implant sites and 10% of patients at the five-to-ten-year mark. This is not a rare complication. One in five implant sites with long-term follow-up develops the condition. The question is not whether peri-implantitis happens. The question is which factors determine whether it happens to any particular patient.

The bacteria that drive peri-implantitis are, predominantly, the same gram-negative anaerobic species that drive periodontitis. This is clinically important: a patient who has a history of periodontal disease, or who has active periodontal disease at the time of implant placement, is carrying the bacterial profile and the host immune susceptibility that predispose to peri-implantitis. Placing implants in such a patient without first treating and stabilising the periodontal disease is placing a fixture into an environment that already has the conditions for failure.

The cascade

The word “cascade” is apt because each step in peri-implantitis progression creates the conditions for the next step.

Step 1: Biofilm accumulation. Bacteria colonise the surface of the implant, particularly at and below the level of the gingival margin. An implant that has been placed with an emergence profile that creates a ledge, an overhang, or a difficult-to-clean contour provides a protected niche for biofilm accumulation. An implant that is not cleaned adequately by the patient accumulates the same biofilm without the architectural problem. Both produce the same first step.

Step 2: Soft-tissue inflammation. The biofilm triggers an inflammatory response in the peri-implant tissues. The gingiva becomes oedematous, bleeds on gentle probing, and may ulcerate. This is peri-implant mucositis. At this stage, thorough decontamination can still reverse the process. Most patients who develop this stage do not present to a clinician, because bleeding gums during brushing are extremely common and not alarming to the general public.

Step 3: Crestal bone loss. When the inflammation is not resolved, the immune mediators of the inflammatory response begin to activate osteoclasts, the bone-resorbing cells. Crestal bone starts to resorb. On a radiograph this appears as a progressive widening of the radiolucent space around the coronal portion of the implant. One millimetre of crestal bone loss in the first year of loading is considered within the range of normal remodelling. Loss that continues beyond the first year is pathological.

Step 4: The positive feedback loop. As crestal bone resorbs, the rough surface of the implant body, designed to promote osseointegration when buried in bone, becomes exposed to the oral environment. Rough surfaces harbour bacteria more effectively than smooth ones. The now-exposed implant surface generates more biofilm, more inflammation, and more bone loss. The cascade accelerates. Probing depths increase. Suppuration may appear. The implant, which began as a firmly integrated fixture, develops progressive mobility.

Step 5: Implant failure and site destruction. A mobile implant must be removed. At the time of removal, the bone defect around the implant site will reflect the degree of bone loss that has occurred. In severe cases this is a large three-dimensional defect with loss of the alveolar ridge architecture. The bone that was present when the implant was placed is gone. The site that might have received a replacement implant cannot do so without first receiving bone grafting, and the grafting will attempt to rebuild what was lost on a timeline of months with outcome uncertainty that is higher than for primary implant placement.

Why the tourism model accelerates this cascade

Peri-implantitis occurs in patients treated everywhere, not only in Turkey or other dental tourism destinations. But the combination of factors that accelerates progression from step one to step five is more commonly present in the dental tourism context than in well-managed domestic implant practice.

Pre-treatment periodontal status not assessed. The three-to-five-day treatment window described in the timeline biology piece does not accommodate a proper periodontal assessment, treatment, and stabilisation period before implant placement. A patient with undiagnosed or untreated periodontal disease who receives implants is at elevated peri-implantitis risk from the outset. She does not know this. The clinic has not told her, because doing so would either require treating the periodontal disease before placement (extending the treatment timeline by months) or declining to proceed (losing the case).

No follow-up. Peri-implantitis is most easily managed at step two, when the inflammation is soft-tissue-only and reversible. Step two is identified through routine implant maintenance: an examination at four and twelve months post-placement, probing around the implant, assessment of crestal bone on radiograph, and professional decontamination if early signs are present. A patient who had implants placed in Antalya and has flown home to Birmingham or Sydney is not attending four-month implant maintenance appointments at the placing clinic. Her local dentist, if she attends, may or may not probe around the implant (many general practitioners are uncertain about their obligations to maintain implants they did not place). The early-intervention window closes.

Implant design and placement factors. High-volume clinics operating at price points that are competitive in the international market use a range of implant systems, some of which are well-documented and others of which are generic systems whose long-term survival data in the peer-reviewed literature is thin. The materials piece addresses this directly. An implant placed with an emergence profile not customised to the patient’s anatomy, using a system whose surface characteristics are not well-characterised, in a quantity (six to eight per arch for a full-arch reconstruction) that produces a complex occlusal environment, starts life at higher peri-implantitis risk than a single implant placed by a specialist in a staged and monitored protocol.

No records and no implant identification. The BDJ’s 2025 aftermath review describes domestic clinicians receiving patients with failed implants who cannot identify the implant brand, the lot number, the placement date, or the post-operative radiographic baseline. Without a baseline radiograph taken shortly after placement, it is impossible to determine how much bone loss has occurred and at what rate. Without implant identification, the correct removal tool cannot be selected. The management of the case, from the perspective of the domestic clinician who did not place the fixture, begins in a position of partial blindness.

What bone loss means for future treatment

This is the part the patient almost never understands before she books.

If an implant fails through peri-implantitis and the site has sustained significant bone loss, the patient is not in the position she was in before the implant was placed. She is in a worse position. She has:

• Lost the bone she started with in that site.
• Undergone a procedure that did not deliver what it promised.
• Potentially compromised adjacent teeth or implants if the infection spread laterally.
• Incurred the cost of the original treatment, which failed.
• Now faces the cost of treatment to manage the failure, which may include implant removal, infection management, and extensive bone grafting.

Bone grafting can, in many cases, rebuild lost ridge volume sufficiently to support a subsequent implant. But the outcome is less predictable than primary placement, the healing time is longer, the surgical complexity is higher, and the cost is substantially more than the original procedure. In cases where soft tissue as well as bone has been compromised, or where infection has extended to adjacent sites, subsequent implant placement may not be feasible at all.

The patient who arrived with a missing tooth and good bone volume, paid for an implant at a tourist-market price point, developed peri-implantitis due to missed pre-treatment screening and absent follow-up, had the implant fail, and then requires extensive reconstruction is not merely a patient who had bad luck with one procedure. She is a patient who has been moved from a straightforward clinical situation to a complex one, at her own expense, by a treatment pathway that did not include the conditions required to produce the outcome it promised.

The Euronews 2022 investigation quotes one patient who received implants that subsequently failed and was quoted €30,000 for repair work, roughly three to four times what she originally paid. That arithmetic is consistent with the clinical reality: managing a failed implant site, with bone grafting and re-implantation, costs more than the original procedure. The savings of the first visit become the debt of the second.

What pre-treatment screening should look like

Before any implant placement, the questions whose answers determine peri-implantitis risk are specific and verifiable.

Periodontal status. Full periodontal charting of the remaining dentition. Any sites with probing depths above 4 mm, bleeding on probing, or furcation involvement need active periodontal treatment and a period of stabilisation before implant placement is appropriate. This is not a bureaucratic requirement. It is the prerequisite for placing implants into an environment that will not immediately predispose them to failure.

Radiographic bone survey. A full periapical series or a CBCT that allows assessment of bone levels around all remaining teeth and in the proposed implant sites. Generalised bone loss in the dentition is a risk marker for peri-implantitis regardless of implant placement technique.

Systemic risk factors. Uncontrolled diabetes (HbA1c above 7%) impairs healing and is associated with higher peri-implantitis risk. Active smoking doubles the failure risk at five years. Bisphosphonate use creates risk of osteonecrosis. A medical history that does not surface these factors is a history taken too quickly.

Oral hygiene assessment. An implant cannot be maintained by a patient who cannot adequately clean their natural teeth. A full-mouth plaque score and a realistic assessment of the patient’s home care capacity is part of the pre-implant workup. If the score is high, the implant does not go in until home care improves. This takes weeks to months, not days.

A clinic that processes international patients through a three-to-five-day window cannot complete this assessment and act on its findings. The assessment is compressible in theory. The treatment of the findings is not. A three-day timeline cannot accommodate “your gums need four to eight weeks of periodontal treatment before we can proceed.”

What the patient should ask

If you are considering implants through a dental tourism pathway, the questions whose answers distinguish a clinic that has screened you appropriately from one that has not are these:

Has full periodontal charting been done on all remaining teeth, and what were the findings? If the answer is “you had a check and everything looked fine,” that is not a periodontal charting.

Have bone levels around all remaining teeth been assessed radiographically? If the answer is “we took an OPG,” be aware that OPG is a screening tool, not a definitive bone-level assessment.

Is there a maintenance protocol for after implant placement, and who provides it if you are not near the treating clinic? If the answer is “see your local dentist,” the clinic does not have a follow-up protocol. It has a discharge instruction.

What implant system will be used, and is published peer-reviewed survival data available for that system? The answer should include a brand name, a surface specification, and the ability to provide you with a reference to published data. “We use only the best implants” is not an answer.

The dental tourism trust gap explains why these questions are difficult to ask and harder to verify from the outside, and what verification is actually possible before treatment begins. The cross-border liability review explains what options you have when the answers to these questions turn out to have been wrong.

What would change this assessment

Peri-implantitis is not a dental tourism problem. It is a dental implant problem. The underlying epidemiology, the cascade mechanism, and the risk factors are the same regardless of where the implant was placed. My assessment that the dental tourism context accelerates the cascade rests on three specific claims: that pre-treatment periodontal screening is inadequate in the high-volume three-to-five-day model; that follow-up maintenance is absent for returned international patients; and that implant system selection in the price-sensitive tourist market includes systems with thinner peer-reviewed survival evidence.

Any of these claims would revise if contradicted by prospective data: a study following international dental-tourism implant patients with standardised pre-treatment periodontal screening documentation, post-placement maintenance records, and implant-system provenance would allow direct comparison to domestic staged-protocol benchmarks. That study does not exist. The inference from the clinical pattern is the best available evidence. It is what the 86% of UK dentists who have treated these patients are seeing, and the direction of the signal is consistent.

For the pre-treatment bone-grafting decision that determines whether a site is ready for an implant at all, see the bone grafting materials review. For the sinus-specific version of this problem in the posterior upper jaw, see the Leanne Abeyance case analysis. For the broader Turkey teeth picture and the structural argument behind the failure pattern, see the Turkey teeth honest account. For what happens to the patient’s legal and insurance position when this failure occurs, see the cross-border dental liability review. For the economic incentive that produces rushed treatment in the first place, see the overtreatment economics piece.